Hunting Hill Global Capital’s SpringWorks Therapeutics SWTX Stock Holding History

Hunting Hill Global Capital’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-31,119	Closed	-$1.46M	–	149
2025 Q2	$1.46M	Buy	31,119 +16,761	+117%	+$746K	0.4%	41
2025 Q1	$634K	Buy	+14,358	New	+$661K	0.39%	46

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hunting Hill Global Capital's SWTX Position: Q3 2025 in Review

Hunting Hill Global Capital sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 31,119 shares — an estimated $1.46M sold.

Hunting Hill Global Capital first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $1.46M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Hunting Hill Global Capital reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Hunting Hill Global Capital sold 31,119 SpringWorks Therapeutics shares in Q3 2025, an estimated $1.46M.
Hunting Hill Global Capital first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Hunting Hill Global Capital's SpringWorks Therapeutics position peaked at $1.46M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Hunting Hill Global Capital's 13F filing for Q3 2025, filed 14 Nov 2025.